{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:04:40Z","timestamp":1791443080751,"version":"4.3.3"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"crossref","award":["R218-A13160"],"award-info":[{"award-number":["R218-A13160"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24463-0","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:28:10Z","timestamp":1763555290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BIGH3 is a mediator of TGF\u03b2-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target"],"prefix":"10.1038","volume":"15","author":[{"given":"Nicholas","family":"Willumsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Bager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette T.","family":"Hansen Seln\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled E.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Alexander","family":"Skarsfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel I.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus S.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Thorlacius-Ussing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten H.","family":"Dziegiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hung Eric","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi M. H.","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24463_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/JCI93554","volume":"128","author":"M Yamauchi","year":"2018","unstructured":"Yamauchi, M., Barker, T. H., Gibbons, D. L. & Kurie, J. M. The fibrotic tumor stroma. J. Clin. Invest. 128, 16\u201325 (2018).","journal-title":"J. Clin. Invest."},{"key":"24463_CR2","doi-asserted-by":"crossref","unstructured":"Willumsen, N. et al. Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types. Cellular and Molecular Life Sciences 2022 79:4 79, 1\u201311 (2022).","DOI":"10.1007\/s00018-022-04226-0"},{"key":"24463_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","volume":"121","author":"MA Karsdal","year":"2017","unstructured":"Karsdal, M. A. et al. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv. Drug Deliv Rev. 121, 43\u201356 (2017).","journal-title":"Adv. Drug Deliv Rev."},{"key":"24463_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/JHC.S275008","volume":"7","author":"C Jensen","year":"2020","unstructured":"Jensen, C. et al. Cross-Linked multimeric Pro-Peptides of type III collagen (PC3X) in hepatocellular Carcinoma - A biomarker that provides additional prognostic value in AFP positive patients. J. Hepatocell Carcinoma. 7, 301\u2013313 (2020).","journal-title":"J. Hepatocell Carcinoma"},{"key":"24463_CR5","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/liv.15595","volume":"43","author":"S Johansen","year":"2023","unstructured":"Johansen, S. et al. Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease. Liver Int. 43, 1486\u20131496 (2023).","journal-title":"Liver Int."},{"key":"24463_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","volume":"38","author":"NI Nissen","year":"2019","unstructured":"Nissen, N. I., Karsdal, M. & Willumsen, N. Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology. J. Experimental Clin. Cancer Res. 38, 115 (2019).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"24463_CR7","doi-asserted-by":"crossref","unstructured":"Walker, C., Mojares, E., Del R\u00edo Hern\u00e1ndez, A. Role of extracellular matrix in development and cancer progression. Int J. Mol. Sci 19, 3028 (2018).","DOI":"10.3390\/ijms19103028"},{"key":"24463_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X Meng","year":"2016","unstructured":"Meng, X., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"24463_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","volume":"1832","author":"LA Borthwick","year":"2013","unstructured":"Borthwick, L. A., Wynn, T. A. & Fisher, A. J. Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta Mol. Basis Dis. 1832, 1049\u20131060 (2013).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"24463_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00262-017-2003-1","volume":"66","author":"H Jiang","year":"2017","unstructured":"Jiang, H., Hegde, S. & DeNardo, D. G. Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. Cancer Immunol. Immunother. 66, 1037\u20131048 (2017).","journal-title":"Cancer Immunol. Immunother."},{"key":"24463_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02133-z","volume":"40","author":"C Jensen","year":"2021","unstructured":"Jensen, C., Nissen, N. I., Arenstorff, V., Karsdal, C. S., Willumsen, N. & M. A. & Serological assessment of collagen fragments and tumor fibrosis May guide immune checkpoint inhibitor therapy. J. Experimental Clin. Cancer Res. 40, 1\u201311 (2021).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"24463_CR12","doi-asserted-by":"crossref","unstructured":"Naik, A., Leask, A. Tumor-Associated fibrosis impairs the response to immunotherapy. Matrix Biology 119, 125-140 (2023).","DOI":"10.1016\/j.matbio.2023.04.002"},{"key":"24463_CR13","first-page":"303","volume":"5","author":"MJ Nielsen","year":"2013","unstructured":"Nielsen, M. J. et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am. J. Transl Res. 5, 303\u2013315 (2013).","journal-title":"Am. J. Transl Res."},{"key":"24463_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14030819","volume":"14","author":"NI Nissen","year":"2022","unstructured":"Nissen, N. I. et al. Collagen biomarkers quantify fibroblast activity in vitro and predict survival in patients with pancreatic ductal adenocarcinoma. Cancers (Basel). 14, 1\u201321 (2022).","journal-title":"Cancers (Basel)"},{"key":"24463_CR15","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1002\/ijc.31627","volume":"143","author":"A Lipton","year":"2018","unstructured":"Lipton, A. et al. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Int. J. Cancer. 143, 3027\u20133034 (2018).","journal-title":"Int. J. Cancer"},{"key":"24463_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-018-0474-z","volume":"6","author":"C Jensen","year":"2018","unstructured":"Jensen, C. et al. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint Blockade (anti-CTLA-4) in metastatic melanoma patients. J. Immunother Cancer. 6, 1\u201310 (2018).","journal-title":"J. Immunother Cancer"},{"key":"24463_CR17","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1002\/ijc.32751","volume":"146","author":"IM Chen","year":"2019","unstructured":"Chen, I. M. et al. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer. Int. J. Cancer. 146, 2913\u20132922 (2019).","journal-title":"Int. J. Cancer"},{"key":"24463_CR18","doi-asserted-by":"publisher","first-page":"19761","DOI":"10.1038\/s41598-019-56268-3","volume":"9","author":"N Willumsen","year":"2019","unstructured":"Willumsen, N. et al. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer. Sci. Rep. 9, 19761 (2019).","journal-title":"Sci. Rep."},{"key":"24463_CR19","doi-asserted-by":"publisher","first-page":"e001193","DOI":"10.1136\/jitc-2020-001193","volume":"8","author":"DP Hurkmans","year":"2020","unstructured":"Hurkmans, D. P. et al. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 Inhibition in patients with metastatic melanoma. J. Immunother Cancer. 8, e001193 (2020).","journal-title":"J. Immunother Cancer"},{"key":"24463_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79608-0","volume":"11","author":"NI Nissen","year":"2021","unstructured":"Nissen, N. I. et al. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab. Sci. Rep. 11, 1\u201312 (2021).","journal-title":"Sci. Rep."},{"key":"24463_CR21","doi-asserted-by":"crossref","unstructured":"Wang, S. et al. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase Alfa. J. Transl Med. 19, 39 (2021).","DOI":"10.1186\/s12967-021-02701-z"},{"key":"24463_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer. NPJ Breast Cancer. 7, 108 (2021).","journal-title":"NPJ Breast Cancer"},{"key":"24463_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-022-04226-0","volume":"79","author":"N Willumsen","year":"2022","unstructured":"Willumsen, N. et al. Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types. Cell. Mol. Life Sci. 79, 1\u201311 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"24463_CR24","doi-asserted-by":"crossref","unstructured":"Christensen, T. D. et al. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer. Int J. Cancer 152, 1036-1049 (2022).","DOI":"10.1002\/ijc.34356"},{"key":"24463_CR25","doi-asserted-by":"crossref","unstructured":"Thorlacius-Ussing, J., Kristensen, S. R., Karsdal, M. A., Willumsen, N. & Pedersen, S. Preliminary investigation of elevated collagen and blood-clotting markers as potential noninvasive biomarkers for small cell lung cancer. Thorac Cancer 14, 2830-2838 (2023).","DOI":"10.1111\/1759-7714.15066"},{"key":"24463_CR26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3390\/biomedicines9121920","volume":"9","author":"AL Mak","year":"2021","unstructured":"Mak, A. L. et al. Systematic review with Meta-Analysis: diagnostic accuracy of Pro-C3 for hepatic fibrosis in patients with Non-Alcoholic fatty liver disease. Biomedicines 9, 1920 (2021).","journal-title":"Biomedicines"},{"key":"24463_CR27","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/liv.15595","volume":"43","author":"S Johansen","year":"2023","unstructured":"Johansen, S. et al. Validation of scores of <\u2009scp\u2009>\u2009PRO-C3\u2009to predict liver\u2010related events in alcohol\u2010related liver disease. Liver Int. 43, 1486\u20131496 (2023).","journal-title":"Liver Int."},{"key":"24463_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12931-022-02116-4","volume":"23","author":"C Hesse","year":"2022","unstructured":"Hesse, C. et al. Nintedanib modulates type III collagen turnover in viable precision-cut lung slices from bleomycin-treated rats and patients with pulmonary fibrosis. Respir Res. 23, 201 (2022).","journal-title":"Respir Res."},{"key":"24463_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/00365513.2022.2119598","volume":"82","author":"TS Lau","year":"2022","unstructured":"Lau, T. S. et al. Association between fibrosis markers and kidney function following peptide receptor radionuclide therapy in patients with neuroendocrine tumours. Scand. J. Clin. Lab. Invest. 82, 446\u2013453 (2022).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"24463_CR30","doi-asserted-by":"crossref","unstructured":"Baba, A. B. et al. Transforming growth Factor-Beta (TGF-\u03b2) signaling in Cancer-A betrayal within. Front Pharmacol 13, 79127 (2022).","DOI":"10.3389\/fphar.2022.791272"},{"key":"24463_CR31","doi-asserted-by":"crossref","unstructured":"Kim, B. G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., Driscoll, J. J. Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. J Hematol. Oncol 14, 55 (2021).","DOI":"10.1186\/s13045-021-01053-x"},{"key":"24463_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/dna.1992.11.511","volume":"11","author":"J Skonier","year":"1992","unstructured":"Skonier, J. et al. cDNA cloning and sequence analysis of \u03b2ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth Factor-\u03b2. DNA Cell Biol. 11, 511\u2013522 (1992).","journal-title":"DNA Cell Biol."},{"key":"24463_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/1523-1747.ep12607024","volume":"104","author":"RG LeBaron","year":"1995","unstructured":"LeBaron, R. G. et al. \u03b2IG-H3, a novel secretory protein inducible by transforming growth factor-\u03b2, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J. Invest. Dermatology. 104, 844\u2013849 (1995).","journal-title":"J. Invest. Dermatology"},{"key":"24463_CR34","doi-asserted-by":"publisher","first-page":"30907","DOI":"10.1074\/jbc.M002752200","volume":"275","author":"JE Kim","year":"2000","unstructured":"Kim, J. E. et al. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-\u03b2-induced gene, \u03b2ig-h3. J. Biol. Chem. 275, 30907\u201330915 (2000).","journal-title":"J. Biol. Chem."},{"key":"24463_CR35","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.biocel.2007.06.004","volume":"39","author":"N Thapa","year":"2007","unstructured":"Thapa, N., Lee, B. H. & Kim, I. S. TGFBIp\/\u03b2ig-h3 protein: A versatile matrix molecule induced by TGF-\u03b2. Int. J. Biochem. Cell. Biology. 39, 2183\u20132194 (2007).","journal-title":"Int. J. Biochem. Cell. Biology"},{"key":"24463_CR36","doi-asserted-by":"publisher","first-page":"10461","DOI":"10.3390\/ijms130810461","volume":"13","author":"MP Ween","year":"2012","unstructured":"Ween, M. P., Oehler, M. K. & Ricciardelli, C. Transforming growth factor-beta-induced protein (TGFBI)\/(\u03b2ig-H3): A matrix protein with dual functions in ovarian cancer. Int. J. Mol. Sci. 13, 10461\u201310477 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"24463_CR37","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.121.058615","volume":"146","author":"CP Manta","year":"2022","unstructured":"Manta, C. P. et al. Targeting of scavenger receptors Stabilin-1 and Stabilin-2 ameliorates atherosclerosis by a plasma proteome switch mediating Monocyte\/Macrophage suppression. Circulation 146, 1783\u20131799 (2022).","journal-title":"Circulation"},{"key":"24463_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4439(02)00052-2","volume":"1588","author":"D Schneider","year":"2002","unstructured":"Schneider, D. et al. Induction and expression of \u00dfig-h3 in pancreatic cancer cells. Biochim. Et Biophys. Acta - Mol. Basis Disease. 1588, 1\u20136 (2002).","journal-title":"Biochim. Et Biophys. Acta - Mol. Basis Disease"},{"key":"24463_CR39","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1021\/pr200527z","volume":"10","author":"A Turtoi","year":"2011","unstructured":"Turtoi, A. et al. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. J. Proteome Res. 10, 4302\u20134313 (2011).","journal-title":"J. Proteome Res."},{"key":"24463_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/gutjnl-2018-317570","volume":"68","author":"D Goehrig","year":"2019","unstructured":"Goehrig, D. et al. Stromal protein \u03b2ig-h3 reprogrammes tumour microenvironment in pancreatic cancer. Gut 68, 693\u2013707 (2019).","journal-title":"Gut"},{"key":"24463_CR41","doi-asserted-by":"crossref","unstructured":"Easton, D. F. & Eeles, R. A. Genome-wide association studies in cancer. Hum Mol. Genet 17, R109-15 (2008).","DOI":"10.1093\/hmg\/ddn287"},{"key":"24463_CR42","doi-asserted-by":"crossref","unstructured":"Sud, A., Kinnersley, B. & Houlston, R. S. Genome-wide association studies of cancer: current insights and future perspectives. Nat Rev. Cancer 17, 692-704 (2017).","DOI":"10.1038\/nrc.2017.82"},{"key":"24463_CR43","doi-asserted-by":"crossref","unstructured":"Sato, G. et al. Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis. Nat Commun 14, 3671 (2023).","DOI":"10.1038\/s41467-023-39136-7"},{"key":"24463_CR44","unstructured":"Neergaard, J. S. et al. Cohort profile: the prospective epidemiological risk factor (PERF) study. Int J. Epidemiol 46, 1104-1104i (2017)."},{"key":"24463_CR45","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1212\/NXG.0000000000000508","volume":"6","author":"MHE Tang","year":"2020","unstructured":"Tang, M. H. E. et al. Matrix metalloproteinase-degraded type I collagen is associated with APOE\/TOMM40 variants and preclinical dementia. Neurol. Genet. 6, e508 (2020).","journal-title":"Neurol. Genet."},{"key":"24463_CR46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4172\/1948-5956-C1-160","volume":"11","author":"I Chen","year":"2019","unstructured":"Chen, I. et al. Identification of new biomarkers in patients with pancreatic cancer (BIOPAC): A study protocol of an open cohort study. J. Cancer Sci. Ther. 11, 232 (2019).","journal-title":"J. Cancer Sci. Ther."},{"key":"24463_CR47","first-page":"e13219","volume":"29","author":"K Bagni","year":"2020","unstructured":"Bagni, K. et al. Prognostic impact of charlson\u2019s Age-Comorbidity index and other risk factors in patients with pancreatic cancer. Eur. J. Cancer Care (Engl). 29, e13219 (2020).","journal-title":"Eur. J. Cancer Care (Engl)"},{"key":"24463_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods HHS public access author manuscript. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"24463_CR49","doi-asserted-by":"crossref","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. 4, 7 (2015).","DOI":"10.1186\/s13742-015-0047-8"},{"key":"24463_CR50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell. Res. 29, 725\u2013738 (2019).","journal-title":"Cell. Res."},{"key":"24463_CR51","doi-asserted-by":"crossref","unstructured":"Thorlacius-Ussing, J. et al. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J. Pathol. 262, 22-36 (2024).","DOI":"10.1002\/path.6207"},{"key":"24463_CR52","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1476-5381.2009.00387.x","volume":"158","author":"CZ Chen","year":"2009","unstructured":"Chen, C. Z. et al. The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br. J. Pharmacol. 158, 1196\u20131209 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"24463_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12931-020-01369-1","volume":"21","author":"SR R\u00f8nnow","year":"2020","unstructured":"R\u00f8nnow, S. R. et al. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis. Respir Res. 21, 108 (2020).","journal-title":"Respir Res."},{"key":"24463_CR54","doi-asserted-by":"crossref","unstructured":"Karsdal, M. A. et al. Transforming growth Factor-\u03b2 controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J. Biol. Chem. 278, 44975-44987 (2003).","DOI":"10.1074\/jbc.M303905200"},{"key":"24463_CR55","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904\u2013909 (2006).","journal-title":"Nat. Genet."},{"key":"24463_CR56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1371\/journal.pgen.0020190","volume":"2","author":"N Patterson","year":"2006","unstructured":"Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, 190 (2006).","journal-title":"PLoS Genet."},{"key":"24463_CR57","doi-asserted-by":"crossref","unstructured":"Turner, S. D. Qqman: an R package for visualizing GWAS results using Q-Q and Manhattan plots. BioRxiv 005165 1-2 (2014).","DOI":"10.1101\/005165"},{"key":"24463_CR58","doi-asserted-by":"crossref","unstructured":"Bachy, S. et al. \u03b2ig-h3-structured collagen alters macrophage phenotype and function in pancreatic cancer. iScience 25, 103758 (2022).","DOI":"10.1016\/j.isci.2022.103758"},{"key":"24463_CR59","doi-asserted-by":"crossref","unstructured":"Li, G. et al. The role of macrophages in fibrosis of chronic kidney disease. Biomedicine Pharmacotherapy 177, 117079 (2024).","DOI":"10.1016\/j.biopha.2024.117079"},{"key":"24463_CR60","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-21-0536","volume":"81","author":"LSM Lecker","year":"2021","unstructured":"Lecker, L. S. M. et al. Tgfbi production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer. Cancer Res. 81, 5706\u20135719 (2021).","journal-title":"Cancer Res."},{"key":"24463_CR61","first-page":"2018","volume":"361","author":"V Emilsson","year":"1979","unstructured":"Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 2018 (1979).","journal-title":"Science"},{"key":"24463_CR62","doi-asserted-by":"crossref","unstructured":"Ruffieux, H. et al. A fully joint bayesian quantitative trait locus mapping of human protein abundance in plasma. PLoS Comput. Biol 16, e1007882 (2020).","DOI":"10.1371\/journal.pcbi.1007882"},{"key":"24463_CR63","doi-asserted-by":"crossref","unstructured":"Thareja, G. et al. Differences and commonalities in the genetic architecture of protein quantitative trait loci in European and Arab populations. Hum Mol. Genet 32, 907-916 (2023).","DOI":"10.1093\/hmg\/ddac243"},{"key":"24463_CR64","first-page":"2021","volume":"374","author":"M Pietzner","year":"1979","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, 2021 (1979).","journal-title":"Science"},{"key":"24463_CR65","doi-asserted-by":"crossref","unstructured":"Gudjonsson, A. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat Commun 13, 480 (2022).","DOI":"10.1038\/s41467-021-27850-z"},{"key":"24463_CR66","doi-asserted-by":"crossref","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73-79 (2018).","DOI":"10.1038\/s41586-018-0175-2"},{"key":"24463_CR67","doi-asserted-by":"crossref","unstructured":"Katz, D. H. et al. Whole genome sequence analysis of the plasma proteome in black adults provides novel insights into cardiovascular disease. Circulation 145, 357-370 (2022).","DOI":"10.1161\/CIRCULATIONAHA.121.055117"},{"key":"24463_CR68","doi-asserted-by":"crossref","unstructured":"Suhre, K. et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun 8, 15345 (2017).","DOI":"10.1038\/ncomms14357"},{"key":"24463_CR69","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott, C. J. et al. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clin. Cancer Res. 21, 3561\u20133568 (2015).","journal-title":"Clin. Cancer Res."},{"key":"24463_CR70","doi-asserted-by":"crossref","unstructured":"Liot, S. et al. Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins. Front. Immunol. 12, 612271 (2021).","DOI":"10.3389\/fimmu.2021.612271"},{"key":"24463_CR71","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal, M. A., Martin, T. J., Bollerslev, J., Christiansen, C. & Henriksen, K. Are nonresorbing osteoclasts sources of bone anabolic activity? J. Bone Miner. Res. 22, 487\u2013494 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"24463_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00223-013-9741-7","volume":"94","author":"K Henriksen","year":"2014","unstructured":"Henriksen, K. & Karsdal, M. A. John Martin, T. Osteoclast-Derived coupling factors in bone remodeling. Calcif Tissue Int. 94, 88\u201397 (2014).","journal-title":"Calcif Tissue Int."},{"key":"24463_CR73","doi-asserted-by":"crossref","unstructured":"de la Fouchardi\u00e8re, C. et al. A promising biomarker and therapeutic target in patients with advanced PDAC: the stromal protein \u03b2ig-h3. J. Pers. Med. 12, 623 (2022).","DOI":"10.3390\/jpm12040623"},{"key":"24463_CR74","doi-asserted-by":"publisher","first-page":"110028","DOI":"10.1016\/j.cellsig.2021.110028","volume":"84","author":"A Corona","year":"2021","unstructured":"Corona, A. & Blobe, G. C. The role of the extracellular matrix protein TGFBI in cancer. Cell. Signal. 84, 110028 (2021).","journal-title":"Cell. Signal."},{"key":"24463_CR75","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Pan-Cancer analysis of the associations of TGFBI expression with prognosis and immune characteristics. Front. Mol. Biosci. 8, 745649 (2021).","DOI":"10.3389\/fmolb.2021.745649"},{"key":"24463_CR76","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/labmed\/lmz063","volume":"51","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. Hypoxia-Induced TGFBI as a serum biomarker for laboratory diagnosis and prognosis in patients with pancreatic ductal adenocarcinoma. Lab. Med. 51, 352\u2013361 (2020).","journal-title":"Lab. Med."},{"key":"24463_CR77","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/ijc.32247","volume":"145","author":"B Costanza","year":"2019","unstructured":"Costanza, B. et al. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances Glycolysis and promotes pancreatic cancer cell migration. Int. J. Cancer. 145, 1570\u20131584 (2019).","journal-title":"Int. J. Cancer"},{"key":"24463_CR78","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1111\/cas.13783","volume":"109","author":"T Sato","year":"2018","unstructured":"Sato, T., Muramatsu, T., Tanabe, M. & Inazawa, J. Identification and characterization of transforming growth factor beta-induced in Circulating tumor cell subline from pancreatic cancer cell line. Cancer Sci. 109, 3623\u20133633 (2018).","journal-title":"Cancer Sci."},{"key":"24463_CR79","doi-asserted-by":"crossref","unstructured":"Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Lim\u00f3n, P. The polarization of immune cells in the tumour environment by TGF-beta. Nat. Rev. Immunol. 10, 554-567 (2010).","DOI":"10.1038\/nri2808"},{"key":"24463_CR80","first-page":"521","volume":"55","author":"SG Lee","year":"2023","unstructured":"Lee, S. G. et al. TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway. Exp. Mol. Med. 55, 521\u2013530 (2023).","journal-title":"Exp. Mol. Med."},{"key":"24463_CR81","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.4049\/jimmunol.180.7.5036","volume":"180","author":"N Nacu","year":"2008","unstructured":"Nacu, N. et al. Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J. Immunol. 180, 5036\u20135044 (2008).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24463-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:05:35Z","timestamp":1763557535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24463-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24463"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24463-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NWI, KH, CB, ATHS, KEM, DJL, MKS, NIN, RSP, JTU, MAK, MHET: employed at Nordic Bioscience. KH, ATHS, KEM: employed at KeyBioscience. AS, AB, PV: employed at Bristol Myers Squibb. IC: research funding from Roche, Bristol Myers Squibb\/Celgene, Genis, Varian Medical Systems, AstraZeneca and Genmab; travel and accommodations expenses from Roche, Bristol Myers Squibb\/Celgene, Bayer; advisory role for Amgen, AstraZeneca, and ANOCCA. JSJ, MHD, LNJ, HMHD: declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40867"}}